UCB.BR
Price:
$203.5
Market Cap:
$38.75B
UCB S.A., a biopharmaceutical enterprise founded in 1925 and headquartered in Brussels, Belgium, focuses on developing innovative solutions for individuals living with neurological and immunological diseases. Its diverse commercialized portfolio includes Cimzia, targeting inflammatory TNF-mediated conditions such as Crohn's disease, various forms of spondyloarthritis, rheumatoid arthritis, and psoriasis. For epilepsy management, UCB offers Vimpat, Keppra, and Briviact, along with Nayzilam, an intranasal rescue treatment for seizure clusters. Neupro is available for Parkinson's disease and restless legs syndrome, while Zyrtec and Xyzal address allergy symptoms. Other key products include Even...[Read more]
Industry
Biotechnology
IPO Date
1987-01-01
Stock Exchange
BRU
Ticker
UCB.BR
According to UCB S.A.’s latest financial reports and current stock price. The company's current ROE is 19.48%. This represents a change of 136.53% compared to the average of 8.24% of the last 4 quarters.
The mean historical ROE of UCB S.A. over the last ten years is 10.23%. The current 19.48% ROE has changed 90.52% with respect to the historical average. Over the past ten years (40 quarters), UCB.BR's ROE was at its highest in in the December 2025 quarter at 9.97%. The ROE was at its lowest in in the June 2007 quarter at 0%.
Average
10.23%
Median
10.94%
Minimum
3.82%
Maximum
14.34%
Discovering the peaks and valleys of UCB S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 177.86%
Maximum Annual ROE = 14.34%
Minimum Annual Increase = -63.45%
Minimum Annual ROE = 3.82%
| Year | ROE | Change |
|---|---|---|
| 2025 | 14.34% | 35.01% |
| 2024 | 10.62% | 177.86% |
| 2023 | 3.82% | -17.13% |
| 2022 | 4.61% | -63.45% |
| 2021 | 12.62% | 25.32% |
| 2020 | 10.07% | -10.52% |
| 2019 | 11.25% | -11.25% |
| 2018 | 12.68% | -2.13% |
| 2017 | 12.95% | 39.10% |
| 2016 | 9.31% | 100.07% |
The current ROE of UCB S.A. (UCB.BR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.59%
5-year avg
9.20%
10-year avg
10.23%
UCB S.A.’s ROE is less than argenx SE (21.66%), less than Amgen Inc. (89.32%), greater than AbbVie Inc. (-136.50%), less than Regeneron Pharmaceuticals, Inc. (13.81%), less than AstraZeneca PLC (21.68%), less than Eli Lilly and Company (92.58%), less than Incyte Corporation (29.70%), less than Celltrion, Inc. (9.08%), less than Novartis AG (29.64%), less than Vertex Pharmaceuticals Incorporated (23.31%),
| Company | ROE | Market cap |
|---|---|---|
| 21.66% | $45.30B | |
| 89.32% | $223.69B | |
| -136.50% | $490.17B | |
| 13.81% | $77.36B | |
| 21.68% | N/A | |
| 92.58% | $1.11T | |
| 29.70% | $22.95B | |
| 9.08% | $41.19T | |
| 29.64% | $226.38B | |
| 23.31% | $129.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like UCB S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like UCB S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is UCB S.A.'s ROE?
How is the ROE calculated for UCB S.A. (UCB.BR)?
What is the highest ROE for UCB S.A. (UCB.BR)?
What is the 3-year average ROE for UCB S.A. (UCB.BR)?
What is the 5-year average ROE for UCB S.A. (UCB.BR)?
How does the current ROE for UCB S.A. (UCB.BR) compare to its historical average?